FI880059A0 - Foerfarande foer framstaellning av antikroppkonjugater av folsyraanalogers aminderivat. - Google Patents
Foerfarande foer framstaellning av antikroppkonjugater av folsyraanalogers aminderivat.Info
- Publication number
- FI880059A0 FI880059A0 FI880059A FI880059A FI880059A0 FI 880059 A0 FI880059 A0 FI 880059A0 FI 880059 A FI880059 A FI 880059A FI 880059 A FI880059 A FI 880059A FI 880059 A0 FI880059 A0 FI 880059A0
- Authority
- FI
- Finland
- Prior art keywords
- conjugates
- antibody
- vivo
- methods
- folic acid
- Prior art date
Links
- -1 amine derivatives of folic acid analogs Chemical class 0.000 abstract 3
- 229940127121 immunoconjugate Drugs 0.000 abstract 3
- 238000001727 in vivo Methods 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 230000001613 neoplastic effect Effects 0.000 abstract 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86103786A | 1986-05-08 | 1986-05-08 | |
| PCT/US1987/000992 WO1987006837A1 (fr) | 1986-05-08 | 1987-05-01 | CONJUGUES D'ANTICORPS DE DERIVES D'AMINE D'ANALOGUES DE l'ACIDE FOLIQUE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI880059A0 true FI880059A0 (fi) | 1988-01-07 |
| FI880059A FI880059A (fi) | 1988-01-07 |
Family
ID=25334695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI880059A FI880059A (fi) | 1986-05-08 | 1988-01-07 | Foerfarande foer framstaellning av antikroppkonjugater av folsyraanalogers aminderivat. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0251455B1 (fr) |
| JP (1) | JP2564586B2 (fr) |
| AT (1) | ATE105484T1 (fr) |
| AU (1) | AU7359087A (fr) |
| CA (1) | CA1330378C (fr) |
| DE (1) | DE3789788T2 (fr) |
| DK (1) | DK5188A (fr) |
| ES (1) | ES2051738T3 (fr) |
| FI (1) | FI880059A (fr) |
| WO (1) | WO1987006837A1 (fr) |
| ZA (1) | ZA873305B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK8189A (da) * | 1988-01-12 | 1989-07-13 | Bunge Australia | Antigen-antistof-konjugater, deres fremstilling og anvendelse |
| US5144012A (en) * | 1988-08-08 | 1992-09-01 | Eli Lilly And Company | Cytotoxic drug conjugates |
| US5028697A (en) * | 1988-08-08 | 1991-07-02 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers |
| US5066789A (en) * | 1988-09-30 | 1991-11-19 | Neorx Corporation | Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages |
| JPH04504248A (ja) * | 1988-09-30 | 1992-07-30 | ネオロクス コーポレーション | シッフ塩基で結合した、ターゲティング物質―診断／治療薬複合体 |
| AU633538B2 (en) * | 1988-11-18 | 1993-02-04 | Regents Of The University Of California, The | Conjugated polypeptides and methods for their preparation and use |
| US5157123A (en) * | 1989-03-13 | 1992-10-20 | Georgetown University | S-(2-thiopyridyl)-l-cysteine, a heterobifunctional crosslinking reagent |
| US5208008A (en) * | 1990-11-14 | 1993-05-04 | University Of Pittsburgh | Regioselective chemical modification of monoclonal antibodies |
| US5547668A (en) * | 1995-05-05 | 1996-08-20 | The Board Of Trustees Of The University Of Illinois | Conjugates of folate anti-effector cell antibodies |
| ES2197265T3 (es) | 1997-05-09 | 2004-01-01 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Conjugado que comprende un anatagonista de aacido folico y un portador. |
| JP6017422B2 (ja) | 2010-08-10 | 2016-11-02 | エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） | 赤血球結合療法 |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| ES2874884T3 (es) | 2014-02-21 | 2021-11-05 | Ecole Polytechnique Fed De Lausanne Epfl Epfl Tto | Compuestos terapéuticos dirigidos a la glucosa |
| US10309959B2 (en) | 2014-12-03 | 2019-06-04 | Life Technologies Corporation | Charged reactive oligomers |
| US10246410B2 (en) * | 2014-12-03 | 2019-04-02 | Life Technologies Corporation | Hydrazinyl and aminooxy compounds and their methods of use |
| US11253579B2 (en) | 2017-06-16 | 2022-02-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1595101A (en) * | 1977-03-15 | 1981-08-05 | Hoffmann La Roche | Enzyme modifier immunoassay |
| FR2402664A1 (fr) * | 1977-09-07 | 1979-04-06 | Agronomique Inst Nat Rech | Produits de couplage phosphorylcholine, composes amines procede d'obtention et applications |
| CA1203164A (fr) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Conjugats d'anticorps |
| US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| JPS59186924A (ja) * | 1983-04-08 | 1984-10-23 | Kureha Chem Ind Co Ltd | ヒト免疫グロブリン結合抗腫瘍剤 |
| US4584375A (en) * | 1984-08-21 | 1986-04-22 | Rensselaer Polytechnic Institute | Fluorine-containing antifolates incapable of polyglutamate formation |
| WO1986001720A1 (fr) * | 1984-09-13 | 1986-03-27 | Cytogen Corporation | Conjugues d'agents therapeutiques-anticorps |
-
1987
- 1987-04-30 CA CA000536091A patent/CA1330378C/fr not_active Expired - Fee Related
- 1987-05-01 AU AU73590/87A patent/AU7359087A/en not_active Abandoned
- 1987-05-01 JP JP62502915A patent/JP2564586B2/ja not_active Expired - Fee Related
- 1987-05-01 WO PCT/US1987/000992 patent/WO1987006837A1/fr active Application Filing
- 1987-05-07 ES ES87304093T patent/ES2051738T3/es not_active Expired - Lifetime
- 1987-05-07 AT AT8787304093T patent/ATE105484T1/de active
- 1987-05-07 EP EP87304093A patent/EP0251455B1/fr not_active Expired - Lifetime
- 1987-05-07 DE DE3789788T patent/DE3789788T2/de not_active Expired - Fee Related
- 1987-05-08 ZA ZA873305A patent/ZA873305B/xx unknown
-
1988
- 1988-01-07 DK DK005188A patent/DK5188A/da not_active Application Discontinuation
- 1988-01-07 FI FI880059A patent/FI880059A/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK5188D0 (da) | 1988-01-07 |
| ATE105484T1 (de) | 1994-05-15 |
| DE3789788T2 (de) | 1994-08-18 |
| FI880059A (fi) | 1988-01-07 |
| JP2564586B2 (ja) | 1996-12-18 |
| CA1330378C (fr) | 1994-06-21 |
| WO1987006837A1 (fr) | 1987-11-19 |
| EP0251455A2 (fr) | 1988-01-07 |
| EP0251455B1 (fr) | 1994-05-11 |
| ZA873305B (en) | 1987-11-02 |
| ES2051738T3 (es) | 1994-07-01 |
| AU7359087A (en) | 1987-12-01 |
| DE3789788D1 (de) | 1994-06-16 |
| EP0251455A3 (en) | 1990-09-05 |
| DK5188A (da) | 1988-04-15 |
| JPS63503144A (ja) | 1988-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI880059A (fi) | Foerfarande foer framstaellning av antikroppkonjugater av folsyraanalogers aminderivat. | |
| DE3853792D1 (de) | Amin-Derivate von Anthracyclin-Antibiotika. | |
| CA1064826A (fr) | Dimere fixateur d'antigenes lie a un medicament | |
| NO885199D0 (no) | Fremgangsmte for fremstilling av monoklonale antistoffkonjugater. | |
| US4046722A (en) | Immunological materials | |
| FI981807A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten starburst-konjugaattien valmistamiseksi | |
| DK434188A (da) | Antistof-enzymkonjugater i kombination med prolaegemidler til fremfoering af cytotoxiske midler til tumorceller | |
| PT97639B (pt) | Processo para a preparacao de hidrazinas n-substituidas bifuncionais e de composicoes farmaceuticas que as contem | |
| EP0354729A2 (fr) | Conjugués de médicaments cytotoxiques | |
| AU619614B2 (en) | Antibody-drug conjugates | |
| PT84932B (pt) | Processo para a preparacao de conjugados de imunoglobulinas | |
| FI104234B1 (fi) | Menetelmä vasta-ainekonjugaattien valmistamiseksi neoplastisten sairauksien hoitoon | |
| NO861200L (no) | Fremgangsmaate for fremstilling av konjugater av metallthioneiner og biologisk aktive molkyler. | |
| USRE38994E1 (en) | Pyropheophorbides conjugates and their use in photodynamic therapy | |
| CA2121990A1 (fr) | Conjugues anticorps-medicament | |
| ATE178493T1 (de) | Stabilisierte antikörperfragmente | |
| FR2350845A1 (fr) | Produit conjugue pour la suppression des anticorps reaginiques a la penicilline et sa preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: CYTOGEN CORPORATION |